Introduction
Vascular endothelial cells are heavily covered with a glycocalyx, which has been shown to be differently modified with α2,3-or α2,6-sialic acids (Born and Palinski 1985; Cioffi et al. 2012) . Endothelial cells secrete von Willebrand factor carrying α2,3-sialic acid, and its deficiency by deleting sialyltransferase ST3Gal IV results in the production of asialoglycan on its molecule, leading to rapid clearance by hepatic asialoglycoprotein receptors (Grewal et al. 2008; Sorensen et al. 2009 ). The biological significance of α2,6-sialic acids was recognized almost 20 years ago, and several reports have shown that α2,6-sialylated glycoproteins expressed in vascular endothelial cells mediate the binding of B lymphocyte adhesion molecule CD22, and that the level of endothelial α2,6-sialic acid is increased in an inflammatory cytokine-dependent manner (Hanasaki et al. 1994 (Hanasaki et al. , 1995 Nitschke et al. 1999) . Conversely, sialidase treatment in vivo prevents attachment of lymphocytes to specialized blood vessels known as high endothelial venules (Rosen et al. 1989) . Therefore, it was originally considered that endothelial α2,6-sialic acid is mainly involved in the interaction between endothelial cells and circulating lymphocytes. Moreover, sialidase treatment results in disruption of cell-cell and cell-matrix adhesion (Cioffi et al. 2012) , indicating that sialic acids play a fundamental role in the endothelial barrier function.
Thus, the biological importance of endothelial sialic acid has been appreciated, but the underlying molecular mechanism that ensures sialic acid-dependent endothelial integrity has been poorly understood. We recently found that one of the major endothelial adhesion molecules, platelet endothelial cell adhesion molecule (PECAM), has a lectin-like activity toward α2,6-sialic acid and that this lectin activity is critical not only for the homophilic PECAM interaction but also for endothelial viability (Kitazume et al. 2014) . PECAM is expressed in vascular endothelial cells, platelets, and subtypes of leukocytes Woodfin et al. 2007 ). Since the identification of PECAM cDNA in 1990 (Newman et al. 1990; Simmons et al. 1990; Stockinger et al. 1990 ), accumulating evidence has emphasized that PECAM is a multifunctional molecule. This review will focus on a limited part of PECAM biology, in which we would like to discuss how recognition of α2,6-sialic acid by endothelial PECAM is related to the previously identified role of PECAM.
Brief overview of PECAM structure and function PECAM is an 130 kDa type I membrane glycoprotein that belongs to an Ig superfamily. The extracellular domain of PECAM comprises six Ig domains and seven N-glycans, and each Ig domain has at least one N-glycan ( Figure. 1) . The cytoplasmic domain of PECAM receives phosphorylation to several serine and tyrosine residues . There are two immunoreceptor tyrosine inhibitory motifs (ITIMs) in the cytoplasmic domain. Phosphorylation of tyrosine residues within the motifs occurs in response to mechanical force, osmotic shock or cross-linking of PECAM to itself, and the phosphorylated motifs can serve as docking sites for protein tyrosine phosphatases, such as Src homology 2 domaincontaining protein tyrosine phosphatase 2 (SHP2), which are then activated to transduce inhibitory signals to the cell (Newman et al. 1990; Woodfin et al. 2007) . β-Catenin is also recruited to the cytoplasmic domain of PECAM and links PECAM to the actin cytoskeleton.
Basically, the extracellular domain of PECAM is related to its homo-and heterophilic interactions (Wong et al. 2000) , while the cytoplasmic region is involved in the transduction of various cellular signals. Homo-and heterophilic PECAM interactions can occur via the first Ig domain (Domain 1) (Newton et al. 1997; Woodfin et al. 2007) . Even though PECAM is considered to have dual roles through homo-and heterophilic interactions, accumulating data support the idea that the principal ligand for PECAM is PECAM itself and that the homophilic PECAM interaction leads to the transduction of anti-apoptotic signals to endothelial cells (Newton et al. 1997; Bird et al. 1999) . It has been suggested that signals originating from the PECAM extracellular domain lead to the association of one or more cytosolic signaling molecules with the PECAM cytoplasmic tail, resulting in the transmission of prosurvival signals that suppress the mitochondria-dependent, Bax-mediated intrinsic apoptotic pathway .
A number of other putative heterophilic PECAM ligands, such as integrin αVβ3 (Piali et al. 1995; Buckley et al. 1996) , ADP-ribose cyclase (CD38) (Deaglio et al. 1998 ) and CD177 (Sachs et al. 2007 ) have also been identified. Notably, Igdomain 6 of endothelial PECAM or an anti-CD177 antibody was shown to inhibit neutrophil transmigration toward chemotactic gradients, indicating that the heterophilic PECAM interaction with CD177 is important for neutrophil transmigration. A previously identified mechanosensory complex, which comprises PECAM, vascular endothelial cadherin (VE-cadherin) and vascular endothelial growth factor receptor 2 (VEGFR2), can be considered to be one of the most important concepts regarding the heterophilic interaction of PECAM with other functional molecule(s). Shear stress is a fundamental determinant for maintaining vascular homeostasis, and this mechanosensory complex was shown to be sufficient to confer responsiveness, such as downstream integrin activation (Tzima et al. 2005) . The importance of the PECAM molecule as a mechanosensor is indicated by the fact that PECAM deficiency results in impairment of the downstream integrin activation.
PECAM is a sialic acid-specific lectin Several lines of evidence indicate the existence of a sialic aciddependent homophilic PECAM interaction. First, PECAM can be precipitated with beads conjugated with a Siaα2,6-Galbinding lectin, Sambucus sieboldiana agglutinin (Kitazume et al. 2010; Lee et al. 2014) , indicating that PECAM itself has α2,6-sialic acid. Furthermore, mass spectrometry analysis of the N-glycan released from PECAM purified from mouse lung revealed the presence of a sialylated biantennary structure Fig. 1 . Schematic structure of PECAM. In the extracellular region, there are six Ig domains and seven N-glycans, for which a typical α2,6-sialylated complex biantennary glycan is shown. In the cytoplasmic region, there are two ITIMs, and tyrosine phosphorylation within these motifs results in the recruitment of signal transducing molecules, such as SHP2 phosphatase. β-Catenin is also recruited to the cytoplasmic region. The N-terminal Ig domain mediates the homophilic PECAM interaction, while multiple Ig domains are involved in the heterophilic PECAM interaction. The issue of which Ig domain is responsible for the lectin property of PECAM remains to be clarified. Fig. 2 . Analysis of PECAM mutants suggests a different glycan recognition mode compared with CD22. PECAM-His was incubated with a series of Fc-PECAM mutants, in which either well-conserved basic amino acid residue (s) within the N-terminal Ig domain or the N-glycosylation site was mutated, and pulled down by Dynabeads protein G (Kitazume et al. 2010) . The relative levels of PECAM-His bound to immobilized PECAM-Fc mutants were quantified by western blot analysis. The data are shown as means ± SE, when the level of PECAM-His pulled down with wild-type PECAM-Fc was set at 100% (n = 3). *P < 0.05.
PECAM is a sialic acid-specific lectin (Kitazume et al. 2014) . Second, kinetic analysis of cell surfacebiotinylated PECAM in endothelial cells prepared from wildtype and ST6Gal I-deficient mice showed that the half-life of cell surface PECAM is significantly decreased by the lack of α2,6-sialic acid, and that more PECAM is localized to the early endosome. Moreover, sialidase pretreatment diminishes the PECAM-PECAM interaction in vitro (Kitazume et al. 2010) and in endothelial cells (Lee et al. 2014) . Conversely, ST6Gal I overexpression enhances the cell surface expression of PECAM in human umbilical vein endothelial cells (Kitazume et al. 2010) . Third, α2,6-sialylated pentasaccharides possess significantly higher inhibitory activity toward the homophilic PECAM interaction in vitro than α2,3-sialylated pentasaccharides (Kitazume et al. 2014) , although this inhibitory effect has not been clearly observed for asialo-oligosaccharides and shorter oligosaccharides, including α2,6-sialyllactose.
In addition, our recent study showed that endothelial PECAM has a weak, but significant, glycan recognition activity toward α2,6-sialylated glycans (Kitazume et al. 2014) . Even though the glycan-binding activity of PECAM is too weak to assess by glycan array analysis, which was successfully used to observe the sialic acid-binding activity of Siglecs such as CD22 (Blixt et al. 2004 ), binding of a cluster-type α2,6-sialyl N-glycan probe to recombinant PECAM is detectable, indicating that a multivalent α2,6-sialyl probe can overcome the low affinity of the glycan-binding property of PECAM (Lundquist and Toone 2002) . Although PECAM and CD22 share a similar specificity for α2,6-sialylated oligosaccharides, PECAM exhibits a lower specificity for α2,6-sialic acid and a much lower affinity than CD22. It is known that a V-set domain in the N-terminal Ig domain is key for determining the specificity of Siglecs, including CD22 (Crocker et al. 2007 ). Despite several pieces of information emphasizing the importance of the first Ig domain for the homophilic PECAM interaction, the PECAM K106A -Fc mutant, in which a well-conserved basic amino acid within the first Ig domain is mutated, possesses more than 60% binding activity to PECAM-His compared with wild-type PECAM-Fc ( Figure. 2) . Clarification of the three-dimensional PECAM structure will be necessary in future to compare the glycan-binding motifs between PECAM and CD22.
Lectin activity and angiogenesis
An important question is how this newly discovered lectin activity of PECAM is related to the previously described Fig. 3 . Level of α2,6-sialylation regulates angiogenesis. A high level of α2,6-sialic acid in endothelial cells supports the homophilic PECAM interaction and stabilizes the mechanosensory complex to transduce cell survival signals. When the level of endothelial α2,6-sialic acid is low, the homophilic PECAM interaction is impaired. Meanwhile, VEGFR2 carrying a low level of α2,6-sialic acid glycan can be detected with galectin-1 secreted from tumor cells to sustain tumor angiogenesis.
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multifaceted biological role of PECAM. In α2,6-sialic aciddeficient endothelial cells, both tyrosine phosphorylation of PECAM and SHP2 recruitment to PECAM are significantly reduced (Kitazume et al. 2010) , indicating that PECAMdependent signaling is impaired by the absence of the PECAM glycan ligand. Importantly, endothelial cells that lack α2,6-sialic acid are more susceptible to mitochondriadependent apoptotic stimuli. Moreover, a recent finding showed that Neu1 sialidase acts on PECAM to reduce its sialylation, leading to the impairment of endothelial tube formation and angiogenesis (Lee et al. 2014) . Taken together, the lectin activity of PECAM supports the homophilic PECAM interaction and is critical for anti-apoptotic activity. Although the issue of how the absence of endothelial PECAM affects the cell viability against various apoptotic stimuli remains somewhat controversial (Bird et al. 1999; Noble et al. 1999; Gao et al. 2003; Park et al. 2010) , such differences could arise from the cell culture conditions and the different origins from which the endothelial cells were isolated.
In addition, it is difficult to compare the deficiency of PECAM and ST6Gal I from the same point of view. ST6Gal I deficiency causes alterations to the glycan structure of various endothelial glycoproteins, including other Ig superfamily members such as vascular cell adhesion molecule 1 (Abe et al. 1999 ) and intracellular adhesion molecule 1 (Scott et al. 2013) , and other types of cell adhesion molecules such as integrins and VE-cadherin (Geyer et al. 1999) . Likewise, removal of sialic acid by sialidases including NEU1 affects various endothelial glycoproteins. As the lectin activity of PECAM reasonably contributes to the heterophilic interaction with another functional complexes carrying α2,6-sialic acid, ST6Gal I deficiency can cause dissociation of such PECAM partners. The exact role of PECAM-1 in light of its α2,6-sialylation in endothelial function is not fully understood and should be further investigated.
A recent interesting finding showed that galectin-1 selectively binds to the N-glycans of VEGFR2 to activate VEGF-independent signaling, which is related to anti-VEGF antibody-insensitive tumor angiogenesis (Croci et al. 2014) . It is known that α2,6-sialylation of N-acetyllactosamine blocks the binding of galectin-1 (Toscano et al. 2007 ). Furthermore, endothelial cells express NEU1 sialidase that disrupts capillarylike tube formation possibly by removing sialic acid from PECAM (Cross et al. 2012; Lee et al. 2014) . In light of the accumulating new findings, endothelial sialylation regulates angiogenesis in a remarkable way. The level of endothelial α2,6-sialic acid is regulated by ST6Gal I expression, which is induced by proinflammatory cytokines such as TNFα and IL-1β (Hanasaki et al. 1994) . Higher α2,6-sialylation promotes the homophilic PECAM interaction and possibly stabilizes the mechanosensory complex to retain endothelial cell survival ( Figure. 3). Meanwhile, immunosuppressive stimuli reduce α2,6-sialic acid, leading to an increase in galectin-1 permissive glycans (Croci et al. 2014) . Furthermore, when tumor cells are deprived of oxygen, the hypoxic conditions induce secretion of galectin-1 as well as VEGF from tumor cells. Galectin-1 binds to VEGFR2 carrying a low level of α2,6-sialic acid and transduces proliferation signaling, otherwise apoptotic signaling would be transduced to endothelial cells in the absence of the homophilic PECAM interaction.
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